Related references
Note: Only part of the references are listed.Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections
Filip Jansaker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli
Arne Soraas et al.
PLOS ONE (2014)
Regional Resistance Surveillance Program Results for 12 Asia-Pacific Nations (2011)
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Alternatives to carbapenems in ESBL-producing Escherichia coli infections
D. Fournier et al.
MEDECINE ET MALADIES INFECTIEUSES (2013)
Use of Gentamicin for Women with Community-Acquired Uncomplicated Acute Pyelonephritis Caused by Gentamicin-Susceptible or -Resistant Escherichia coli: 10-Year Experience
Seong-Heon Wie et al.
MICROBIAL DRUG RESISTANCE (2013)
Empirical Use of Ciprofloxacin for Acute Uncomplicated Pyelonephritis Caused by Escherichia coli in Communities Where the Prevalence of Fluoroquinolone Resistance Is High
Jae Hyun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
Galo Peralta et al.
BMC INFECTIOUS DISEASES (2012)
Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in french children
Andre Birgy et al.
BMC INFECTIOUS DISEASES (2012)
Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
Sun Hee Park et al.
BMC INFECTIOUS DISEASES (2012)
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2012)
Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection
Meltem Isikgoz Tasbakan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial
Torsten Sandberg et al.
LANCET (2012)
Emergence of Extended-Spectrum β-Lactamase-Producing Escherichia coli as a Cause of Community-Onset Bacteremia in South Korea: Risk Factors and Clinical Outcomes
Sun Hee Park et al.
MICROBIAL DRUG RESISTANCE (2011)
Clinical Guideline for the Diagnosis and Treatment of Urinary Tract Infections: Asymptomatic Bacteriuria, Uncomplicated & Complicated Urinary Tract Infections, Bacterial Prostatitis
INFECTION AND CHEMOTHERAPY (2011)
Community-Onset Bacteremia Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
The epidemiology of urinary tract infection
Betsy Foxman
NATURE REVIEWS UROLOGY (2010)
Matching Methods for Causal Inference: A Review and a Look Forward
Elizabeth A. Stuart
STATISTICAL SCIENCE (2010)
Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
Stanley Xu et al.
VALUE IN HEALTH (2010)
Aminoglycoside drugs in clinical practice: an evidence-based approach
Leonard Leibovici et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
High rate of intestinal colonization with extended-spectrum-β-lactamase-producing organisms in household contacts of infected community patients
Aranzazu Valverde et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Complicated urinary tract infections
Durwood E. Neal
UROLOGIC CLINICS OF NORTH AMERICA (2008)
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
Liat Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
AS Levey et al.
KIDNEY INTERNATIONAL (2005)
Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections
ND Friedman et al.
ANNALS OF INTERNAL MEDICINE (2002)
Share Paper
